Latest News

Kalbe Shares Health Through The Sinabung Movement

Kalbe Shares Health Through The Sinabung Movement

No Press Release 006/KFCP-DIR/PR/II/14

Sinabung, 3 Februari 2014 – PT Kalbe Farma Tbk (Kalbe) today holds health services for 1,785 inhabitants of Sinabung, North Sumatra. The two-day services will be held at four posts, located at Jalan Udara Berastagi, Desa Tanjung and Tanjung Mbelang. The health services provided will include general health check.

“Kalbe is very much concerned of the health of the refugee of Sinabung mountain's eruption," said dr.  Karta Sadana, Medical Deputy Director of PT Kalbe Farma Tbk. “Through this activity, we are hoping to help the recovery of Sinabung. We are collaborating with the National Military, National Disaster Management Agency (BNPB) and the local Government in supplying the logistics of the activity to ensure its continuity.”

This activity involves a team of 13 physicians and 6 pharmacists, and today the medical team will service 659 patients at KWK Berastagi post and 550 patients at Korpi post. On February 4, it will service 366 patients at Tanjung Mbelang post and 210 patients at GBKP RG Tanjung Mbelang post. The health services will provide 96 types of medications.  

Kalbe through Kalbe Shares activities has consistently perform their social responsibility to the community through four pillars: Kalbe Shares Health, which is the base of every social responsibility that is performed; Kalbe Shares Education, by focusing on innovations for healthier Indonesia; Kalbe Shares Environment that commits in guarding a better and healthier environment for a better earth to live in; and Kalbe Shares Infrastructures by placing their concern on supporting infrastructures that increase access and quality of health, education and environment with the principal of building together for a healthier Indonesian communities.

Kalbe at a glance
PT Kalbe Farma Tbk (“Kalbe”) was established in 1966 and is one of the biggest public pharmaceutical companies in Southeast Asia. Kalbe has four main divisions that handle their reliable and diversed brand portfolio, prescription drugs (Cefspan, Brainact, Broadced, etc); over-the-counter drugs (Woods, Promag, Mixagrip, Komix, Fatigon, etc); nutrition (ChilKid, Prenagen, Diabetasol, etc); and distribution business units. Kalbe currently has more than 20 subsidiaries, 9 production facilities with international standard, and employs more than 15,000 employees and 4,000 sales force and marketing agents, dispersed across more than 65 branches throughout Indonesia. From 1991, Kalbe is listed at Indonesia Stock Exchange (IDX:KLBF).

2381 Rate this article:
No rating

Please login or register to post comments.